Europe is on the cusp of approving a gene therapy for the first time, in what would be a landmark moment for the field.
Gene therapies alter a patient's DNA to treat inherited diseases passed from parent to child.
The European Medicines Agency has recommended a therapy for a rare genetic disease which leaves people unable to properly digest fats.
The European Commission will now make the final decision.
Update (July 26): Office hours for September will be Monday, September 3, between 7:30 am and 8:15 am. August office hours will be on Monday, August 6, between 7:30 am and 8:15 am as well.